Mein Warenkorb

DDR1

DDR1 Molekülinformation

Englischer NameDiscoidin domain receptor 1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5Target-AliasEpithelial discoidin domain-containing receptor 1,Epithelial discoidin domain receptor 1,CD167 antigen-like family member A,Cell adhesion kinase,Discoidin receptor tyrosine kinase,HGK2,Mammary carcinoma kinase 10,MCK-10,Protein-tyrosine kinase 3A,Protein-tyrosine kinase RTK-6,TRK E,Tyrosine kinase DDR,Tyrosine-protein kinase CAK,CD167a,CD167 Antigen-Like Family Member A,TRKE,RTK6,PTK3A Protein Tyrosine Kinase 3A,PTK3A,NTRK4,Neurotrophic Tyrosine Kinase, Receptor, Type 4,Neuroepithelial Tyrosine Kinase,NEP,MCK10,EDDR1,Discoidin Domain Receptor Tyrosine Kinase 1,Discoidin Domain Receptor Family, Member 1,CD167a Antigen,CAK,CD167
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameDiscoidin domain receptor 1
Target-AliasEpithelial discoidin domain-containing receptor 1,Epithelial discoidin domain receptor 1,CD167 antigen-like family member A,Cell adhesion kinase,Discoidin receptor tyrosine kinase,HGK2,Mammary carcinoma kinase 10,MCK-10,Protein-tyrosine kinase 3A,Protein-tyrosine kinase RTK-6,TRK E,Tyrosine kinase DDR,Tyrosine-protein kinase CAK,CD167a,CD167 Antigen-Like Family Member A,TRKE,RTK6,PTK3A Protein Tyrosine Kinase 3A,PTK3A,NTRK4,Neurotrophic Tyrosine Kinase, Receptor, Type 4,Neuroepithelial Tyrosine Kinase,NEP,MCK10,EDDR1,Discoidin Domain Receptor Tyrosine Kinase 1,Discoidin Domain Receptor Family, Member 1,CD167a Antigen,CAK,CD167
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

DDR1 Produktliste

  • Attribut

    Protein (3)

  • Produktbibliothek

    Online (3)

  • Spezies

    Human (2)Mouse (1)

  • Etikett

    Fc Tag (2)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (2)Biotin-labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
HOT
DD1-H82E9
Human
HEK293
Biotinylated Human DDR1 Protein, His,Avitag™ (MALS verified)
In den Warenkorb legen
DD1-H5258
Human
HEK293
Human DDR1 Protein, Fc Tag
In den Warenkorb legen
DD1-M5259
Mouse
HEK293
Mouse DDR1 Protein, Fc Tag
In den Warenkorb legen
Gesamtmenge3
  • 1

DDR1 Molekülhintergrund

Discoidin domain receptor 1 (DDR1) is a member of DDRs, which are members of the receptor tyrosine kinase (RTK). Upon collagen binding, DDR1 undergoes tyrosine autophosphorylation, which consequently triggers downstream genetic and cellular pathways and plays critical roles in the regulation of cellular morphogenesis, differentiation, proliferation, adhesion, migration, and invasion. Research shows that DDR1 is closely related to various human diseases including cancer, fibrosis, atherosclerosis, and other inflammatory disorders. New generation DDR1 inhibitors targeting the allosteric sites outside of the canonical ATP-binding pocket or extracellular domain (allosteric inhibitors) may offer a new opportunity for selective DDR1 inhibition therapy development.

DDR1 Molekülalias

CD167a

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Merestinib5OGS5K699E; LY-2801653Phase 2 ClinicalEli Lilly And CompanyBiliary Tract Neoplasms; Solid tumours; Skin Melanoma; Bone metastases; Pancreatic Neoplasms; Neoplasms; Microsatellite instability-high cancer; Breast Neoplasms; Cholangiocarcinoma; Lymphoma, Mantle-Cell; Colorectal Neoplasms; Gallbladder Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung
Details
PRTH-101PRTH-101Phase 1 ClinicalThe George Washington University Milken Institute School Of Public Health (Gwu), Parthenon Therapeutics IncSolid tumours; Neoplasms
Details
ICP-033ICP-033Phase 1 ClinicalBeijing Innocare Pharma Tech Co LtdSolid tumours
Details
AVI-4015AVI-4015Phase 1 ClinicalAvixgenDry Eye Syndromes
Details
AGX-0073AGX-0073Phase 1 ClinicalShanghai Aojian Biological Technology Co LtdSolid tumours
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns